Top compounds associated with response to MLYCD


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.05 0.2
mRNA YM-155 CTRPv2 pan-cancer AAC -0.054 0.2
mRNA cediranib CTRPv2 pan-cancer AAC 0.077 0.2
mRNA BCL-LZH-4 CTRPv2 pan-cancer AAC -0.077 0.2
mRNA momelotinib CTRPv2 pan-cancer AAC 0.049 0.2
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.051 0.2
mRNA niclosamide CTRPv2 pan-cancer AAC -0.05 0.2
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.048 0.2
mRNA PL-DI CTRPv2 pan-cancer AAC 0.044 0.2
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.05 0.2
Download CSV